 regimen-rel toxic busulfan-cyclophosphamid condit regimen patient undergo allogen bone marrow transplant regimen-rel toxic rrt busulfan mg/kg cyclophosphamid mg/kg regimen buci consecut patient allogen bone marrow transplant hematolog malign patient toxic grade organ system cardiac bladder renal pulmonari hepat cn stomat gastrointestin rrt scale set patient diseas treatment paramet age sex diagnosi eastern cooper oncolog group ecog score liver function test lft chemotherapi exposur diseas statu graft-versus-host diseas gvhd prophylaxi antimicrobi agent use hematolog recoveri sever acut gvhd signific predictor rrt common signific organ toxic stomat patient grade II IV hepat patient grade II IV renal gastrointestin toxic uncommon seriou grade II IV patient grade iii toxic follow system hepat pulmonari cn femal frequent stomat hepat rrt patient methotrex gvhd prophylact regimen grade II IV stomat hepat rrt use amphotericin antibiot cours grade II IV hepat rrt multivari analysi administr grade II IV hepat rrt incid acut gvhd grade II IV gvhd estim event-fre surviv ef entir studi group estim ef standard-risk patient acut leukemia first remiss chronic myelogen leukemia cml first stabl phase other high-risk patient high-risk patient risk diseas recurr rrt buci efficaci bone marrow transplant regimen standard-risk patient leukemia signific hepat rrt